The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
Related Articles
Top Biotech, With 85% Gain This Week, Rockets Again On Sale
The company is adding onto its success outperforming Merck’s top drug in lung cancer patients.
Navigating the inevitable: artificial intelligence and the future of scientific communication – PubMed
Navigating the inevitable: artificial intelligence and the future of scientific communication
The extracellular matrix in solid tumor immunotherapy
The extracellular matrix (ECM) of solid tumors impacts the antitumor activities of CD8+ T and natural killer (NK) cells in a variety of ways. Cell…
$SUNCAT | AIRDROP
500,000 Maximum per wallet 500,000 Maximum per wallet The official $SUNCAT community airdrop is now live, all holders are eligible to enter the airdrop campaign!…
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
https://www.globenewswire.com/news-release/2024/09/12/2944984/0/en/ITM-Obtains-Exclusive-Worldwide-License-from-Debiopharm-for-CA-IX-Targeted-Peptide-based-Radiopharmaceutical-Programs-Targeting-Solid-Tumors.html?pdf=1
Ministers pressing Treasury to fund ‘a lot of prevention projects’
The Department of Health and Social Care is fighting for funding for ‘a lot of public health projects’ in the upcoming government spending review, a…
One ricochet of the ivonescimab bullet
The small cap biotech Instil Bio tries to follow in Summit’s slipstream.
President’s Corner: Dr. Frederick Chite Asirwa Establishes Oncology
2024-2025 ASCO president Dr. Robin Zon and Dr. Frederick Chite Asirwa discuss collaboration, embracing community, and how by working together, we are stronger than cancer.
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023